Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AA Dentallaboratorium ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   4.4% 9.4% 6.1% 5.7% 6.8% 4.0% 18.2% 17.9%   Credit score (0-100)   49 27 38 39 34 48 8 8   Credit rating   BBB BB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,247 1,982 2,259 2,622 2,370 2,079 0.0 0.0   EBITDA   345 -339 90.7 79.5 -71.0 200 0.0 0.0   EBIT   321 -363 63.0 59.2 -85.8 174 0.0 0.0   Pre-tax profit (PTP)   318.7 -363.5 54.3 48.0 -101.9 127.6 0.0 0.0   Net earnings   318.7 -363.5 54.3 48.0 -101.9 127.6 0.0 0.0   Pre-tax profit without non-rec. items   319 -364 54.3 48.0 -102 128 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   109 97.6 70.0 49.7 34.9 8.9 0.0 0.0   Shareholders equity total   453 89.2 144 192 89.7 217 167 167   Interest-bearing liabilities   84.8 194 315 302 309 366 0.0 0.0   Balance sheet total (assets)   846 1,104 1,114 1,576 1,353 1,410 167 167   Net Debt   62.5 157 97.4 -229 176 64.7 -167 -167     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,247 1,982 2,259 2,622 2,370 2,079 0.0 0.0   Gross profit growth   29.2% -11.8% 14.0% 16.1% -9.6% -12.3% -100.0% 0.0%   Employees   5 5 5 5 6 4 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 20.0% -33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   846 1,104 1,114 1,576 1,353 1,410 167 167   Balance sheet change%   24.2% 30.5% 0.9% 41.5% -14.1% 4.2% -88.1% 0.0%   Added value   344.9 -339.4 90.7 79.5 -65.5 200.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -47 -35 -55 -41 -30 -52 -9 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 1.0 2.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   14.3% -18.3% 2.8% 2.3% -3.6% 8.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   42.1% -37.3% 5.7% 4.4% -5.7% 12.6% 0.0% 0.0%   ROI %   69.6% -88.5% 17.0% 12.4% -18.7% 35.5% 0.0% 0.0%   ROE %   108.6% -134.2% 46.7% 28.7% -72.4% 83.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   53.5% 8.1% 12.9% 12.2% 6.6% 15.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   18.1% -46.3% 107.4% -288.3% -248.1% 32.3% 0.0% 0.0%   Gearing %   18.7% 217.3% 219.6% 157.9% 344.8% 168.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.6% 0.2% 3.4% 3.6% 5.9% 13.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   0.9 0.6 0.7 0.7 0.6 0.7 0.0 0.0   Current Ratio   1.9 1.0 1.1 1.1 1.0 1.1 0.0 0.0   Cash and cash equivalent   22.4 36.8 217.8 531.7 133.0 301.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   343.8 -8.4 73.5 141.8 54.8 138.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   69 -68 18 16 -11 50 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   69 -68 18 16 -12 50 0 0   EBIT / employee   64 -73 13 12 -14 44 0 0   Net earnings / employee   64 -73 11 10 -17 32 0 0